(Q48022641)

7 February 2018

title

How frequent are notified severe cutaneous adverse reactions to Fansidar? (English)

1 reference

7 February 2018

author name string

D Stürchler

series ordinal

1

1 reference

7 February 2018

M L Mittelholzer

series ordinal

2

1 reference

7 February 2018

L Kerr

series ordinal

3

1 reference

7 February 2018

publication date

1 February 1993

1 reference

7 February 2018

number of pages

9

1 reference

inferred from page(s)

published in

Drug Safety

1 reference

7 February 2018

volume

8

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

160-168

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.2165/00002018-199308020-00006

exact match

0 references

cites work

Risk of malaria in British residents returning from malarious areas

1 reference

12 December 2020

Malaria incidence and prevention among European and North American travellers to Kenya.

1 reference

12 December 2020

Chemosuppressive field trials in Thailand. III. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by a sulfadoxine-pyrimethamine combination

1 reference

12 December 2020

Clinical and etiological aspects of erythema multiforme. A propos of 40 cases

1 reference

12 December 2020

Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine

1 reference

12 December 2020

Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects

1 reference

12 December 2020

Adverse-drug-reaction monitoring

1 reference

12 December 2020

Drug-induced febrile mucocutaneous syndrome with a survey of the literature

1 reference

12 December 2020

Recommendations for the prevention of malaria in travelers.

1 reference

12 December 2020

Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique

1 reference

12 December 2020

Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland

1 reference

12 December 2020

Parenteral Fansidar in falciparum malaria

1 reference

12 December 2020

Does chloroquine contribute to the risk of serious adverse reactions to fansidar?

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

Management of toxic epidermal necrolysis in a pediatric burn center

1 reference

12 December 2020

Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment

1 reference

12 December 2020

Confidence intervals rather than P values: estimation rather than hypothesis testing

1 reference

12 December 2020

Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.

1 reference

12 December 2020

Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases

1 reference

12 December 2020

Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.

1 reference

12 December 2020

A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures

1 reference

12 December 2020

Recurrent Erythema Multiforme and Herpes Genitalis (Type 2)

1 reference

12 December 2020

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

1 reference

12 December 2020

A review of aetiological factors in erythema multiforme

1 reference

12 December 2020

Malaria prophylaxis in travellers to tropical Africa

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985

1 reference

12 December 2020

Prevention of malaria in travelers 1982.

1 reference

12 December 2020

[Cutaneous reactions appearing during the mass prophylaxis of cerebrospinal meningitis with a long-delayed action sulfonamide (apropos of 997 cases)]

1 reference

12 December 2020

Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy

1 reference

12 December 2020

Adverse reactions to pyrimethamine/sulfadoxine

1 reference

12 December 2020

[Persistent acantholytic dermatosis with increased light sensitivity]

1 reference

12 December 2020

Why do some African children develop severe malaria?

1 reference

12 December 2020

Idiosyncratic reaction resembling toxic epidermal necrolysis caused by chloroquine and maloprim

1 reference

12 December 2020

Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories

1 reference

12 December 2020

Acetylator phenotype in sulphonamide resistant falciparum malaria.

1 reference

12 December 2020

Malaria in the Malaysian Army with particular reference to chemosuppressive use.

1 reference

12 December 2020

[Stevens-Johnson syndrome and Mycoplasma pneumoniae infection: presentation of 2 cases]

1 reference

12 December 2020

Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia

1 reference

12 December 2020

Pyrimethamine-sulphadoxine: how great the risk?

1 reference

12 December 2020

Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

1 reference

12 December 2020

An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy

1 reference

12 December 2020

Observations on drug-induced toxic epidermal necrolysis in Singapore

1 reference

12 December 2020

Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis

1 reference

12 December 2020

10.2165/00002018-199308020-00006

Identifiers

DOI

1 reference

7 February 2018

Dimensions Publication ID

1042417033

0 references

1 reference

7 February 2018